Literature DB >> 6252185

Human metabolism of cefotaxime.

D S Reeves, L O White, H A Holt, D Bahari, M J Bywater, R P Bax.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1980        PMID： 6252185     DOI： 10.1093/jac/6.suppl_a.93

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN： 0305-7453            Impact factor:   5.790


× No keyword cloud information.
  23 in total

Review 1.  Pharmacological properties of cephalosporins.

Authors:  W Christ
Journal:  Infection       Date:  1991       Impact factor: 3.553

2.  Comparison of in vitro activity of cefotaxime and desacetylcefotaxime alone and in combination against 320 gram-negative clinical isolates.

Authors:  G Piédrola; I Galan; A Leyva; M C Maroto
Journal:  Drugs       Date:  1988       Impact factor: 9.546

Review 3.  Classification of cephalosporins.

Authors:  J D Williams
Journal:  Drugs       Date:  1987       Impact factor: 9.546

4.  Comparative multiple-dose pharmacokinetics of cefotaxime, moxalactam, and ceftazidime.

Authors:  R Lüthy; J Blaser; A Bonetti; H Simmen; R Wise; W Siegenthaler
Journal:  Antimicrob Agents Chemother       Date:  1981-11       Impact factor: 5.191

5.  A comparison of the pharmacokinetics and tissue penetration of ceftriaxone, moxalactam and cefotaxime.

Authors:  R Wise; J M Andrews
Journal:  Eur J Clin Microbiol       Date:  1983-10       Impact factor: 3.267

6.  Comparative pharmacokinetics of cefoperazone, cefotaxime, and moxalactam.

Authors:  B Kemmerich; H Lode; G Belmega; T Jendroschek; K Borner; P Koeppe
Journal:  Antimicrob Agents Chemother       Date:  1983-03       Impact factor: 5.191

7.  Development and validation of a UHPLC-MS/MS method to measure cefotaxime and metabolite desacetylcefotaxime in blood plasma: a pilot study suitable for capillary microsampling in critically ill children.

Authors:  Yarmarly C Guerra Valero; Tavey Dorofaeff; Jason A Roberts; Jeffrey Lipman; Mark G Coulthard; Louise Sparkes; Steven C Wallis; Suzanne L Parker
Journal:  Anal Bioanal Chem       Date:  2021-05-26       Impact factor: 4.142

8.  In vitro activity of ceftazidime, cefotaxime and piperacillin against multi-resistant gram-negative bacteria tested with a modified agar dilution method.

Authors:  J A Hoogkamp-Korstanje; C A Meijer
Journal:  Eur J Clin Microbiol       Date:  1982-06       Impact factor: 3.267

9.  The cooperation of cefotaxime and desacetyl-cefotaxime with respect to antibacterial activity and beta-lactamase stability.

Authors:  M Limbert; G Seibert; E Schrinner
Journal:  Infection       Date:  1982       Impact factor: 3.553

10.  Clinical pharmacology of cefotaxime in pediatric patients.

Authors:  D A Kafetzis; D C Brater; J Kanarios; C A Sinaniotis; C J Papadatos
Journal:  Antimicrob Agents Chemother       Date:  1981-10       Impact factor: 5.191
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.